At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing: a Population-based Randomized Study
In Brief
A clinical study evaluating FIT(Eiken OC-Sensor) Two-day sampling, FIT(Eiken OC-Sensor) One-year interval, and 4 other interventions for Colorectal Cancer and Stomach Disease. Completed, enrolled 99,314 participants across 1 site.
Detailed Summary
1. The abundant results from this trial will be helpful for assessing the feasibility of increasing stool sampling and shortening screening interval in population setting for lower and upper gastrointestinal tract lesions, their long-term effects, and the respective cost-effectiveness. 2. The study will evaluate the value of population-based screen and treatment for H. pylori infection when the HPSA is combined with the FIT.
Study Details
Timeline
Interventions
Collect two stool samples in two separate days
Screening with one-year interval
One-day sampling
Screening with two-year interval
HpSA for detection of upper gastrointestinal diseases; screen and treat for H. pylori infection. Upper endoscopy for H. pylori carriers. HPSA+FIT compared with FIT alone.
HPSA+FIT compared with FIT alone.